Cited 4 time in
EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Oh, Sunhwa | - |
| dc.contributor.author | Ju, Ji-hyun | - |
| dc.contributor.author | Yang, Wonseok | - |
| dc.contributor.author | Lee, Kyung-min | - |
| dc.contributor.author | Nam, KeeSoo | - |
| dc.contributor.author | Shin, Incheol | - |
| dc.date.accessioned | 2022-07-07T05:39:54Z | - |
| dc.date.available | 2022-07-07T05:39:54Z | - |
| dc.date.issued | 2015-06 | - |
| dc.identifier.issn | 0003-9861 | - |
| dc.identifier.issn | 1096-0384 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/143482 | - |
| dc.description.abstract | Members of the EGFR family are potent mediators of normal cell growth and development. HER2 possesses an active tyrosine kinase domain, but no direct ligand has been identified. To investigate the differential effect of HER2 in breast cell lines, HER2 was overexpressed in MCF-10A, MCF7 and MDA-MB-231 cells. HER2 overexpression promoted proliferation, survival and migration in MCF-10A and MCF-7 cells. No significant differences were seen in proliferation, survival or migration between MDA-MB-231 vec and HER2 cells. The activity of downstream HER2 proteins increased in MCF-10A HER2 and MCF-7 HER2 cells but not in MDA-MB-231 HER2 cells. Exogenously expressed HER2 failed to associate with EGFR or HER3 in MDA-MB-231 cells, while overexpression of HER2 enhanced HER family dimerization in MCF-10A and MCF-7 cells. | - |
| dc.format.extent | 8 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Academic Press | - |
| dc.title | EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.abb.2015.04.008 | - |
| dc.identifier.scopusid | 2-s2.0-84929082091 | - |
| dc.identifier.wosid | 000355031200009 | - |
| dc.identifier.bibliographicCitation | Archives of Biochemistry and Biophysics, v.575, pp 69 - 76 | - |
| dc.citation.title | Archives of Biochemistry and Biophysics | - |
| dc.citation.volume | 575 | - |
| dc.citation.startPage | 69 | - |
| dc.citation.endPage | 76 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | sci | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Biophysics | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Biophysics | - |
| dc.subject.keywordPlus | BREAST EPITHELIAL-CELLS | - |
| dc.subject.keywordPlus | ERBB SIGNALING NETWORK | - |
| dc.subject.keywordPlus | CANCER PROGRESSION | - |
| dc.subject.keywordPlus | PHOSPHATASE | - |
| dc.subject.keywordPlus | RECEPTORS | - |
| dc.subject.keywordPlus | HETERODIMERIZATION | - |
| dc.subject.keywordPlus | OVEREXPRESSION | - |
| dc.subject.keywordPlus | INHIBITION | - |
| dc.subject.keywordPlus | ACTIVATION | - |
| dc.subject.keywordPlus | CARCINOMA | - |
| dc.subject.keywordAuthor | EGFR | - |
| dc.subject.keywordAuthor | HER2 | - |
| dc.subject.keywordAuthor | Triple negative breast cancer | - |
| dc.subject.keywordAuthor | Breast cancer cell | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S000398611500209X?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
